title: Are we facing a potential effective treatment for endometriosis?
authors: Center for Special Minimally Invasive and Robotic Surgery, Palo Alto, California.
authors: Camran R
authors: CR
authors: Nezhat
authors: Center for Special Minimally Invasive and Robotic Surgery, Palo Alto, California.
authors: Erika
authors: E
authors: Balassiano
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D003517:Cyclopentanes / Q000494:pharmacology*; D004715:Endometriosis / Q000378:metabolism*; D005260:Female; D006801:Humans; D059566:M Phase Cell Cycle Checkpoints / Q000187:drug effects*; D010048:Ovarian Cysts / Q000378:metabolism*; D010053:Ovary / Q000187:drug effects*; D011804:Quinolines / Q000494:pharmacology*; D011960:Receptors, Estrogen; D043562:Receptors, G-Protein-Coupled / Q000819:agonists*; D017154:Stromal Cells / Q000187:drug effects*
chemical_list: C517943:1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone; D003517:Cyclopentanes; C109584:GPER1 protein, human; D011804:Quinolines; D011960:Receptors, Estrogen; D043562:Receptors, G-Protein-Coupled